TELA Bio (TELA) Non-Current Debt (2018 - 2026)
TELA Bio's (TELA) quarterly Non-Current Debt came in at $55.9 million in Q1 2026, up 35.35% year-on-year from $41.3 million in Q1 2025, and little changed quarter-over-quarter from $55.7 million in Q4 2025.
TELA Bio (TELA) Non-Current Debt (2018 - 2026) Analysis & Trends
TELA Bio's Non-Current Debt history runs 9 years deep, the most recent figure standing at $55.9 million for Q1 2026.
- On a quarterly basis, Non-Current Debt rose 35.35% year-over-year to $55.9 million in Q1 2026; TTM through Mar 2026 was $55.9 million, a 35.35% increase from a year earlier, with the FY2025 full-year figure at $55.7 million, up 35.33% from the prior year.
- Non-Current Debt was little changed at $55.9 million in Q1 2026 per TELA's latest filing, from $55.7 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $55.9 million in Q1 2026 and bottomed at $31.7 million in Q1 2022.
- The 5-year median for Non-Current Debt is $40.5 million (2023), against an average of $41.6 million.
- Across the five-year window, Non-Current Debt slipped 6.78% in 2025 and jumped 35.35% in 2026, its largest moves.
- Year by year, Non-Current Debt stood at $39.9 million in 2022, then gained by 1.5% to $40.5 million in 2023, then gained by 1.5% to $41.1 million in 2024, then surged by 35.33% to $55.7 million in 2025, then rose by 0.38% to $55.9 million in 2026.
- Per Business Quant, the three latest TELA Non-Current Debt figures stand at $55.9 million (Q1 2026), $55.7 million (Q4 2025), and $41.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 29.64 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.22 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 10.99 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.18 Bn |
| 10 | TELA Bio | 40.65 Mn | 1.11 Mn | 12.52 Mn | 55.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.87 Mn |
| Dec 31, 2025 | 55.65 Mn |
| Sep 30, 2025 | 41.49 Mn |
| Jun 30, 2025 | 38.05 Mn |
| Mar 31, 2025 | 41.28 Mn |
| Dec 31, 2024 | 41.12 Mn |
| Sep 30, 2024 | 40.97 Mn |
| Jun 30, 2024 | 40.82 Mn |
| Mar 31, 2024 | 40.67 Mn |
| Dec 31, 2023 | 40.52 Mn |
| Sep 30, 2023 | 40.36 Mn |
| Jun 30, 2023 | 40.21 Mn |
| Mar 31, 2023 | 40.06 Mn |
| Dec 31, 2022 | 39.92 Mn |
| Sep 30, 2022 | 39.77 Mn |
| Jun 30, 2022 | 39.62 Mn |
| Mar 31, 2022 | 31.67 Mn |
| Dec 31, 2021 | 31.49 Mn |
| Sep 30, 2021 | 31.32 Mn |
| Jun 30, 2021 | 31.15 Mn |